業績紹介

2010年 論文

  • Initial experience of transumbilical laparoendoscopic single-site surgery of partial adrenalectomy in patient with aldosterone-producing adenoma.
    Yuge K, Miyajima A, Hasegawa M, Miyazaki Y, Maeda T, Takeda T, Takeda A, Miyashita K, Kurihara I, Shibata H, Kikuchi E, Oya M.
    BMC Urol. 2010 Nov 23;10:19.
  • [Genitourinary cancers].
    Mizuno R, Oya M.
    Nihon Rinsho. 2010 Aug;68 Suppl 8:485-8. Review. Japanese. No abstract available.
  • [Cis-dichlorodiammineplatinum upregulates angiotensin II type 1 receptors through reactive oxygen species generation and enhances VEGF production in bladder cancer.
    Tanaka N, Miyajima A, Kosaka T, Shirotake S, Hasegawa M, Kikuchi E, Oya M.
    Mol Cancer Ther. 2010 Nov;9(11):2982-92.
  • [Expression of snail in upper urinary tract urothelial carcinoma: prognostic significance and implications for tumor invasion.
    Kosaka T, Kikuchi E, Mikami S, Miyajima A, Shirotake S, Ishida M, Okada Y, Oya M.
    Clin Cancer Res. 2010 Dec 1;16(23):5814-23.
  • [Preimplant factors affecting postimplant CT-determined prostate volume and the CT/TRUS volume ratio after transperineal interstitial prostate brachytherapy with 125I free seeds.
    Sugawara A, Nakashima J, Kunieda E, Nagata H, Asakura H, Oya M, Shigematsu N.
    Radiat Oncol. 2010 Sep 28;5:86.
  • [Clinical impact of bladder biopsies with TUR-BT according to cytology results in patients with bladder cancer: a case control study.
    Matsushima M, Kikuchi E, Hasegawa M, Matsumoto K, Miyajima A, Oya M.
    BMC Urol. 2010 Jun 30;10:12.
  • [Contrast-enhanced ultrasonography of the prostate with Sonazoid.
    Matsumoto K, Nakagawa K, Hashiguchi A, Kono H, Kikuchi E, Nagata H, Miyajima A, Oya M.
    Jpn J Clin Oncol. 2010 Nov;40(11):1099-104.
  • [Regulation of human dendritic cells by a novel specific nuclear factor-kappaB inhibitor, dehydroxymethylepoxyquinomicin.
    Shinoda K, Nakagawa K, Kosaka T, Tanaka N, Maeda T, Kono H, Mizuno R, Kikuchi E, Miyajima A, Umezawa K, Oya M.
    Hum Immunol. 2010 Aug;71(8):763-70.
  • [Non-muscle invasive bladder cancer with concomitant vaginal urothelial carcinoma: a case report and review of the literature.
    Kaneko G, Kikuchi E, Hasegawa M, Miyajima A, Nakagawa K, Kameyama K, Oya M.
    Int J Clin Oncol. 2010 Dec;15(6):626-30.
  • [[mTOR inhibitors].
    Oya M.
    Nihon Rinsho. 2010 Jun;68(6):1067-71. Review. Japanese.
  • [The clinical significance of urine cytology after a radical cystectomy for urothelial cancer.
    Yoshimine S, Kikuchi E, Matsumoto K, Ide H, Miyajima A, Nakagawa K, Oya M.
    Int J Urol. 2010 Jun;17(6):527-32. doi: 10.1111/j.1442-2042.2010.02516.x. Epub 2010 Apr 1.
  • [Gemcitabine and cisplatin chemotherapy induced reversible posterior leukoencephalopathy syndrome in a bladder cancer patient.
    Maeda T, Kikuchi E, Matsumoto K, Yazawa S, Hagiuda J, Miyajima A, Nakagawa K, Fujiwara H, Hoshino H, Oya M.
    Int J Clin Oncol. 2010 Oct;15(5):508-11.
  • [Adrenocortical zonation in humans under normal and pathological conditions.
    Nishimoto K, Nakagawa K, Li D, Kosaka T, Oya M, Mikami S, Shibata H, Itoh H, Mitani F, Yamazaki T, Ogishima T, Suematsu M, Mukai K.
    J Clin Endocrinol Metab. 2010 May;95(5):2296-305.
  • [Potent cytotoxic effect of a novel nuclear factor-kappaB inhibitor dehydroxymethylepoxyquinomicin on human bladder cancer cells producing various cytokines.
    Kodaira K, Kikuchi E, Kosugi M, Horiguchi Y, Matsumoto K, Kanai K, Suzuki E, Miyajima A, Nakagawa K, Tachibana M, Umezawa K, Oya M.
    Urology. 2010 Apr;75(4):805-12.
  • [Late recurrence and progression in non-muscle-invasive bladder cancers after 5-year tumor-free periods.
    Matsumoto K, Kikuchi E, Horiguchi Y, Tanaka N, Miyajima A, Nakagawa K, Nakashima J, Oya M.
    Urology. 2010 Jun;75(6):1385-90. doi: 10.1016/j.urology.2009.09.088. Epub 2010 Jan 29.
  • [Extraperitoneal approach induces postoperative inguinal hernia compared with transperitoneal approach after laparoscopic radical prostatectomy.
    Yoshimine S, Miyajima A, Nakagawa K, Ide H, Kikuchi E, Oya M.
    Jpn J Clin Oncol. 2010 Apr;40(4):349-52.
  • [Role of pelvic lymph node dissection in lymph node-negative patients with invasive bladder cancer.
    Shirotake S, Kikuchi E, Matsumoto K, Yazawa S, Kosaka T, Miyajima A, Nakagawa K, Oya M.
    Jpn J Clin Oncol. 2010 Mar;40(3):247-51.
  • [Docetaxel in combination with prednisolone for hormone refractory prostate cancer.
    Ide H, Kikuchi E, Kono H, Nagata H, Miyajima A, Nakagawa K, Ohigashi T, Nakashima J, Oya M.
    Jpn J Clin Oncol. 2010 Jan;40(1):79-84.
  • [Prognostic stratification in patients who received hormonal therapy for prostate-specific antigen recurrence after radical prostatectomy.
    Ide H, Nakashima J, Kono H, Kikuchi E, Nagata H, Miyajima A, Nakagawa K, Oya M.
    Jpn J Clin Oncol. 2010 Feb;40(2):177-80.
  • [Vitamin E succinate induced apoptosis and enhanced chemosensitivity to paclitaxel in human bladder cancer cells in vitro and in vivo.
    Kanai K, Kikuchi E, Mikami S, Suzuki E, Uchida Y, Kodaira K, Miyajima A, Ohigashi T, Nakashima J, Oya M.
    Cancer Sci. 2010 Jan;101(1):216-23.
  • [Ets-1 and hypoxia inducible factor-1alpha inhibition by angiotensin II type-1 receptor blockade in hormone-refractory prostate cancer.
    Kosaka T, Miyajima A, Shirotake S, Kikuchi E, Hasegawa M, Mikami S, Oya M.
    Prostate. 2010 Feb 1;70(2):162-9.
  • [Activation of the aryl hydrocarbon receptor pathway enhances cancer cell invasion by upregulating the MMP expression and is associated with poor prognosis in upper urinary tract urothelial cancer.
    Ishida M, Mikami S, Kikuchi E, Kosaka T, Miyajima A, Nakagawa K, Mukai M, Okada Y, Oya M.
    Carcinogenesis. 2010 Feb;31(2):287-95.
業績紹介